Market Overview

US Stock Futures Signal Lower Start On Wall Street

US Stock Futures Signal Lower Start On Wall Street
Related PFE
The Street Has Finally Recognized The Exelixis Clinical Program Potential
What Do Versartis' Troubles Mean For Opko Health?
US Market Indexes Gain on Wednesday (GuruFocus)
Related MCUR
12 Biggest Mid-Day Gainers For Monday
10 Biggest Mid-Day Losers For Tuesday

Pre-open movers

US stock futures traded lower in early pre-market trade. Futures for the Dow Jones Industrial Average tumbled 95 points to 17,687.00, while the Standard & Poor's 500 index futures fell 11.60 points to 2,041.50. Futures for the Nasdaq 100 index slipped 22.25 points to 4,205.25.

A Peek Into Global Markets

European markets were mostly lower today, with the Spanish Ibex Index dropping 2.04%, STOXX Europe 600 Index declining 0.96% and German DAX 30 index falling 0.54%. French CAC 40 Index declined 0.26% and London's FTSE 100 Index fell 0.18%.

In Asian markets, Japan's Nikkei Stock Average rose 0.36%, Hong Kong's Hang Seng Index fell 0.64%, China's Shanghai Composite Index climbed 0.62% and India's BSE Sensex tumbled 1.71%.

Broker Recommendation
Analysts at BMO Capital upgraded Pfizer (NYSE: PFE) from Market Perform to Outperform and raised the price target from $33.00 to $36.00.

Pfizer's shares rose 0.55% to close at $33.17 on Friday.

Breaking news

  • Macrocure (NASDAQ: MCUR) today announced that Mark Page, a Managing Director at Credit Suisse in New York, will join Macrocure as Chief Financial Officer effective February 10, 2015. To read the full news, click here.
  • Alibaba Group Holding Limited (NYSE: BABA) and Meizu Technology Corporation Limited announced today that Alibaba Group has agreed to invest US$590 million for a minority stake in Meizu, one of China's leading smartphone manufacturers. To read the full news, click here.
  • CASI Pharmaceuticals, Inc. (NASDAQ: CASI) is pleased to announce that it has received formal meeting minutes from the U.S. Food and Drug Administration (FDA) regarding the clinical and regulatory path leading to market approval of ENMD-2076 for the treatment of Fibrolamellar Carcinoma (FLC). To read the full news, click here.
  • FactSet Research Systems Inc. (NYSE: FDS) today announced it has acquired Code Red, Inc. To read the full news, click here.

Posted-In: BMO Capital US Stock FuturesNews Eurozone Futures Global Pre-Market Outlook Markets


Related Articles (CASI + BABA)

View Comments and Join the Discussion!